Ohio State University
Cogen Bioscience is developing a tumor-antigen-directed platform of products for cancer-specific imaging and detection. The company’s imaging methods allow for pre- and post-operative imaging, along with intraoperative imaging for better detection of cancer during surgery to improve patient survival.
This company will be presenting on Day 3 of DeepTechU 2022. View schedule >>